1. Home
  2. GBX vs NVCR Comparison

GBX vs NVCR Comparison

Compare GBX & NVCR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Greenbrier Companies Inc. (The)

GBX

Greenbrier Companies Inc. (The)

HOLD

Current Price

$51.78

Market Cap

1.8B

Sector

Industrials

ML Signal

HOLD

Logo NovoCure Limited

NVCR

NovoCure Limited

HOLD

Current Price

$12.31

Market Cap

1.5B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
GBX
NVCR
Founded
1974
2000
Country
United States
Switzerland
Employees
N/A
N/A
Industry
Railroads
Medical/Dental Instruments
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.8B
1.5B
IPO Year
1996
2015

Fundamental Metrics

Financial Performance
Metric
GBX
NVCR
Price
$51.78
$12.31
Analyst Decision
Sell
Buy
Analyst Count
2
6
Target Price
$49.00
$28.08
AVG Volume (30 Days)
214.1K
1.7M
Earning Date
04-06-2026
05-20-2026
Dividend Yield
2.44%
N/A
EPS Growth
28.02
21.79
EPS
1.14
N/A
Revenue
$3,240,200,000.00
$655,353,000.00
Revenue This Year
N/A
$7.72
Revenue Next Year
$1.64
$6.74
P/E Ratio
$45.41
N/A
Revenue Growth
N/A
8.28
52 Week Low
$37.77
$9.82
52 Week High
$59.19
$20.05

Technical Indicators

Market Signals
Indicator
GBX
NVCR
Relative Strength Index (RSI) 35.21 48.97
Support Level $44.64 $10.86
Resistance Level $54.15 $13.78
Average True Range (ATR) 1.45 0.78
MACD -0.80 -0.09
Stochastic Oscillator 11.56 23.94

Price Performance

Historical Comparison
GBX
NVCR

About GBX Greenbrier Companies Inc. (The)

Greenbrier Companies Inc supplies equipment and services to international freight transportation markets, designing and marketing freight railcars in North America, Europe, and Brazil through subsidiaries and joint ventures. It provides railcar wheel services, parts, maintenance, and conversion services in North America. The company owns a lease fleet sourced mainly from its manufacturing operations and offers railcar management, regulatory compliance, and leasing services to railroads and owners. It operates two segments: Manufacturing and Leasing & Fleet Management, with the majority of revenue from Manufacturing. The company operates in the U.S. and internationally, with the majority of revenue from the U.S. market.

About NVCR NovoCure Limited

NovoCure Ltd is an oncology company with a propreitary platform technology in United States. Its business involves the development, manufacture and commercialization of Tumor Treating Fields (TTFields) devices, including Optune Gio and Optune Lua, for the treatment of solid tumor cancers. Its pipeline consists of Trident, Lunar-2, Panova-3, Metis and other products and technologies for the treatment of Glioblastoma, Non-smell cell lung cancer and Pancreatic cancer. Geographically, the company derives majority of its revenue from the United States and rest from Germany, Japan and other markets.

Share on Social Networks: